Oil prices hold sharp losses with focus on secondary India tariffs
Laura Oliphant, a director at AEHR Test Systems (NASDAQ:AEHR), sold 5,000 shares of common stock on July 25, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The timing of the sale comes as AEHR trades near its 52-week high of $23, having surged 44% in the past week alone. The shares were sold at a price of $21.5003, for a total transaction value of $107,501.
Following the transaction, Oliphant directly owns 22,978 shares of AEHR Test Systems, which includes shares subject to unvested restricted stock units. Oliphant also indirectly owns 7,665 shares through a trust.
In other recent news, Aehr Test Systems reported a decline in its fiscal fourth-quarter revenue, posting $14.1 million compared to $16.6 million in the same period last year. The company also noted a net loss of $2.9 million, a stark contrast to the GAAP net income of $23.9 million recorded in the previous fiscal year. The revenue fell short of the forecasted $14.8 million, reflecting a 4.73% shortfall, though the earnings per share met expectations. Despite the revenue dip, investor sentiment appeared optimistic, as seen in the aftermarket trading. In a separate development, Aehr Test Systems announced receiving follow-on orders from a leading hyperscaler customer for eight Sonoma ultra-high-power systems. These systems are intended for the volume production test and burn-in of AI processors, and the orders represent more than a doubling of production systems with this customer. The systems are scheduled to ship from Aehr’s Fremont, California facility over the next six months.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.